Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|19|6|495-505

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.19, Iss.6, 2018-05, pp. : 495-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LC-MS Development Strategies for Quantitative Bioanalysis

By  

Current Drug Metabolism, Vol. 7, Iss. 5, 2006-07 ,pp. : 491-502

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative Interference by Cysteine and N-Acetylcysteine Metabolites During the LC-MS/MS Bioanalysis of a Small Molecule

By  

Drug Metabolism Letters, Vol. 3, Iss. 3, 2009-08 ,pp. : 181-190

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of a Recombinant Influenza Vaccine Candidate Using Complementary LC-MS Methods

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. : 1568-1579

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Study of LC/MS and EMIT in Therapeutic Monitoring of Carbamazepine and its Clinical Applications

By  

Current Pharmaceutical Analysis, Vol. 13, Iss. 5, 2017-08 ,pp. : 488-493

Bentham Science Publishers

Access to resources Recommend Favorite

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS

By Zhao M.   Zabelina Y.   Rudek M.A.   Wolff A.C.   Baker S.D.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 33, Iss. 4, 2003-11 ,pp. : 725-733

Elsevier

Access to resources Recommend Favorite